Avalo Therapeutics
AVTX
AVTX
36 hedge funds and large institutions have $39.1M invested in Avalo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less capital invested
Capital invested by funds: $66.1M → $39.1M (-$27M)
Holders
36
Holding in Top 10
–
Calls
$19K
Puts
–
Top Buyers
| 1 | +$2M | |
| 2 | +$474K | |
| 3 | +$473K | |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$215K |
| 5 |
BlackRock
New York
|
+$111K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$1.46M | |
| 3 | -$822K | |
| 4 |
AI
Allostery Investments
Stamford,
Connecticut
|
-$490K |
| 5 |
RWP
RWA Wealth Partners
Newton,
Massachusetts
|
-$258K |
